Several lines of evidence indicate that the AD and AID receive markedly different neuromodulatory inputs suggesting that the NCLd recipient AID population and the NCLd-projecting AD population may serve different functions (Mello et al., 2019; Sen et al., 2019). The gene discussed is AICDA; the disease is Alzheimer disease.